The Safety and Effectiveness of Megace in HIV-Infected Women
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To further evaluate the safety of megestrol acetate (Megace) oral suspension in the treatment
of anorexia and cachexia in HIV-positive women. To compare the effectiveness of 2 doses of
Megace by measurement of weight gain, appetite grade, and other parameters at 12 and 24
weeks.